The Yellow Card Scheme: Patient Reporting of Adverse Drug Reactions and Signals they have Generated

被引：0
|
作者：
Foy, M. [1 ]
Gandhi, S. [1 ]
Suri, S. [1 ]
Cumber, S. [1 ]
Jadeja, M. M. [1 ]
机构：
[1] Med & Healthcare Prod Regulatory Agcy, London, England
来源：
DRUG SAFETY | 2011年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：903 / 903
页数：1
相关论文
共 50 条
  • [1] The yellow card scheme: Evaluation of patient reporting of suspected adverse drug reactions
    Ekins-Daukes, S.
    Irvine, D.
    Wise, L.
    Fiddes, S.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S105 - S105
  • [2] The Yellow Card Scheme: Experience of Patient Reporting of Adverse Drug Reactions 5 Years Since Launch
    Cumber, Sarah L.
    Heffer, Sarah J.
    Gandhi, Shelley
    Avery, Anthony J.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S321 - S321
  • [3] The Yellow Card Scheme for reporting adverse drug reactions (ADRs) by patients in the UK will complement, not replace, the Yellow Card reports
    [J]. Reactions Weekly, 2006, 1109 (1) : 3 - 3
  • [4] How Patient Reporters Identify Adverse Drug Reactions A Qualitative Study of Reporting via the UK Yellow Card Scheme
    Krska, Janet
    Anderson, Claire
    Murphy, Elizabeth
    Avery, Anthony J.
    [J]. DRUG SAFETY, 2011, 34 (05) : 429 - 436
  • [5] Public awareness in Wales of the UK Yellow Card scheme for reporting suspected adverse drug reactions
    Bracchi, Robert C.
    Tseliou, Foteini
    Copeland, Lauren
    Routledge, Philip A.
    Thomas, Alison
    Woods, Fiona
    Adams, Alana
    Walker, Jenna
    Jadeja, Mitul
    Atkinson, Mark D.
    Ashfield-Watt, Pauline
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (08) : 3344 - 3348
  • [6] Assessing the usability of methods of public reporting of adverse drug reactions to the UK Yellow Card Scheme
    Anderson, Claire
    Gifford, Alison
    Avery, Anthony
    Fortnum, Heather
    Murphy, Elizabeth
    Krska, Janet
    Bond, Christine
    [J]. HEALTH EXPECTATIONS, 2012, 15 (04) : 433 - 440
  • [7] The Yellow Card Scheme: Experience of Patient Reporting of Adverse Drug Reaction Since Nationwide Launch
    Barrow, P. L.
    Foy, M.
    Gandhi, S.
    O'Keefe, V.
    King, C.
    Webb, R.
    [J]. DRUG SAFETY, 2009, 32 (10) : 968 - 968
  • [8] The effects of an intervention on the reporting of adverse drug reactions via the yellow card
    Saldaña Valderas, M.
    Merino Kolly, M. N.
    Calderón López, L. M.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 : 41 - 41
  • [9] Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys
    Avery, A. J.
    Anderson, C.
    Bond, C. M.
    Fortnum, H.
    Gifford, A.
    Hannaford, P. C.
    Hazell, L.
    Krska, J.
    Lee, A. J.
    McLernon, D. J.
    Murphy, E.
    Shakir, S.
    Watson, M. C.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (20) : 1 - +
  • [10] Patient reporting in Yellow Card scheme on the increase
    [J]. Reactions Weekly, 2009, 1241 (1) : 1 - 1
12345